Usefulness of urine dipstick test in the management of adverse events associated with immune checkpoint inhibitors

被引:0
|
作者
Izumi, Keishiro [1 ]
Iyoda, Tomokazu [1 ,2 ]
Yokota, Atsuko [3 ]
Kanno, Masahito [2 ]
Hoshi, Masahiro [2 ]
Tokuda, Emi [4 ]
Sasaki, Eisaku [4 ]
Kanazawa, Kenya [1 ]
Kuroda, Junko [2 ]
Saji, Shigehira [1 ,4 ]
机构
[1] Fukushima Med Univ Hosp, Clin Oncol Ctr, 1 Hikarigaoka, Fukushima, Fukushima, Japan
[2] Fukushima Med Univ Hosp, Dept Pharm, 1 Hikarigaoka, Fukushima, Fukushima, Japan
[3] Tochigi Canc Ctr, Dept Pharm, 4-9-13 Yonan, Utsunomiya, Tochigi, Japan
[4] Fukushima Med Univ, Dept Med Oncol, 1 Hikarigaoka, Fukushima, Fukushima, Japan
关键词
Immune checkpoint inhibitor; Urine dipstick test; Patient's diary; Telephone follow-up; Pharmacist; THERAPY MANAGEMENT; URINALYSIS; DIARY;
D O I
10.1007/s00520-024-08928-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PurposeThe usefulness of urine dipstick tests (UDTs) in patients with diabetes has been reported. The aim of the present study was to investigate the utility of self-performed UDTs and patient diaries in the management of impaired glucose tolerance, one of the adverse events of immune checkpoint inhibitors (ICIs).MethodsPatients receiving ICIs underwent self-checks with UDTs twice a week for up to 6 months. Pharmacists checked the results at every patient visit, and by phone every 3 months. The primary endpoint was to prospectively assess whether symptoms recorded in patient diaries and UDTs could reduce unscheduled hospital admissions due to impaired glucose tolerance. The secondary endpoint was the correlation between the symptoms in the patient diaries and UDT results.ResultsA total of 112 patients were enrolled in the study. Out of the 3197 planned self-UDTs, 3128 (97.8%) were performed. Forty-four patients (39.3%) were admitted to the hospital, two (1.8%) of whom were admitted due to abnormal glucose tolerance, with one having a positive UDT. There were 46 unscheduled outpatient visits (41.1%), of which five (4.5%) were due to abnormal glucose tolerance symptoms and four were due to a positive UDT. The correlation between descriptions of fatigue or dry mouth in the patient diaries and positive glucose UDTs was 52.4% in sensitivity and 62.4% in specificity.ConclusionSelf-monitoring of symptoms and self-performing of UDTs could not reduce the emergency hospitalization rate. However, this approach could be effective in the objective monitoring of patient status, especially regarding glucose intolerance occurrences.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Unexpected Adverse Events of Immune Checkpoint Inhibitors
    Shalata, Walid
    Yakobson, Alexander
    Cohen, Aharon Y.
    Goldstein, Iris
    Abu Saleh, Omar
    Dudnik, Yulia
    Rouvinov, Keren
    LIFE-BASEL, 2023, 13 (08):
  • [42] Immune checkpoint inhibitors and neuromuscular adverse events
    Suzuki, Shigeaki
    ANNALS OF ONCOLOGY, 2018, 29 : 35 - 35
  • [43] The pathology of adverse events with immune checkpoint inhibitors
    Koelzer, V. H.
    Glatz, K.
    Bubendorf, L.
    Weber, A.
    Gaspert, A.
    Cathomas, G.
    Lugli, A.
    Zippelius, A.
    Kempf, W.
    Mertz, K. D.
    PATHOLOGE, 2017, 38 (03): : 197 - 207
  • [44] Cutaneous Immune-Related Adverse Events Secondary to Immune Checkpoint Inhibitors and Their Management
    Pach, J.
    Leventhal, J. S.
    CRITICAL REVIEWS IN IMMUNOLOGY, 2022, 42 (04) : 1 - 20
  • [45] Treatment options for immune-related adverse events associated with immune checkpoint inhibitors
    Chen, Yu Hua
    Kovacs, Tamas
    Ferdinandy, Peter
    Varga, Zoltan V.
    BRITISH JOURNAL OF PHARMACOLOGY, 2024,
  • [46] Biomarkers associated with immune-related adverse events induced by immune checkpoint inhibitors
    Guo, An-Jie
    Deng, Qing-Yuan
    Dong, Pan
    Zhou, Lian
    Shi, Lei
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2024, 15 (08):
  • [47] Immune-related adverse events associated with immune checkpoint inhibitors in patients with cancer
    Samanci, Nilay Sengul
    Cikman, Duygu Ilke
    Oruc, Kerem
    Bedir, Sahin
    Celik, Emir
    Degerli, Ezgi
    Derin, Sumeyra
    Demirelli, Fuat Hulusi
    Ozguroglu, Mustafa
    TUMORI JOURNAL, 2021, 107 (04): : 304 - 310
  • [48] IMMUNE-RELATED ADVERSE EVENTS ASSOCIATED WITH IMMUNE CHECKPOINT INHIBITORS IN SPANISH PATIENTS
    Villalobos, L.
    Giraldo-sifuentes, W. A.
    Moran-alvarez, P.
    Arroyo Palomo, J.
    Briones-figueroa, A.
    Rita, C.
    Morell-hita, J. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 511 - 511
  • [49] Bibliometric analysis of rheumatic immune related adverse events associated with immune checkpoint inhibitors
    Zeng, Li
    Ma, Gang
    Chen, Kai
    Zhou, Qiao
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [50] Evaluation of an online tool providing management guidance for adverse events associated with immune checkpoint inhibitors.
    Marcello, Krista
    Obholz, Kevin
    Rosenthal, Kristen
    Weber, Jeffrey S.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35